Challenges and Solutions in Immune-Mediated Inflammatory Disease Trials

Today's shift from organ-based symptom relief to mechanism-based treatment can be effective in treating multiple inflammatory conditions, but many factors must be considered to translate inflammation from the bench to the clinic. Common challenges include implementing a strategy to ensure data quality, enabling patient recruitment and retention, and attracting trial sites and investigators. Listen to this webinar to hear insights from two experts in the field as they discuss solutions to overcome trial challenges with immune-mediated inflammatory diseases (IMIDs) and a range of strategies to improve clinical trial conduct.